{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T09:28:38Z","timestamp":1765704518752},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"39","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1097\/md.0000000000012225","type":"journal-article","created":{"date-parts":[[2018,9,29]],"date-time":"2018-09-29T08:43:45Z","timestamp":1538210625000},"page":"e12225","source":"Crossref","is-referenced-by-count":6,"title":["ST segment elevation myocardial infarction (STEMI) patients are more likely to achieve lipid-lowering treatment goals"],"prefix":"10.1097","volume":"97","author":[{"given":"\u00dcnal","family":"G\u00fcntekin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veysel","family":"Tosun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Ya\u015far","family":"Kilin\u00e7","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00fcnd\u00fczalp","family":"Saydam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Necmettin","family":"Korucuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet Nuri","family":"Bozdemir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-14-20210309","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Effcacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet"},{"key":"R2-14-20210309","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jacl.2010.08.026","article-title":"The effects of adherence and persistence on clinical outcomes in patients treated with statins: a systematic review","volume":"4","author":"Simpson","year":"2010","journal-title":"J Clin Lipidol"},{"key":"R3-14-20210309","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/jama.297.2.177","article-title":"Relationship between adherence to evidence-based pharmacotherapy and longterm mortality after acute myocardial infarction","volume":"297","author":"Rasmussen","year":"2007","journal-title":"JAMA"},{"key":"R4-14-20210309","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1007\/s00125-005-0029-y","article-title":"Rapid emergence of effect of atorvastatin on cardiovascular outcomes in the Collaborative Atorvastatin Diabetes Study (CARDS)","volume":"48","author":"Colhoun","year":"2005","journal-title":"Diabetologia"},{"key":"R5-14-20210309","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/eurheartj\/ehm583","article-title":"The Anglo-Scandinavian Cardiac Outcomes Trial \u2013 Lipid-Lowering Arm: extended observations 2 years after trial closure","volume":"29","author":"Sever","year":"2008","journal-title":"Eur Heart J"},{"key":"R6-14-20210309","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1525-1497.2004.30516.x","article-title":"Suboptimal statin adherence and discontinuation in primary and secondary prevention populations","volume":"19","author":"Ellis","year":"2004","journal-title":"J Gen Intern Med"},{"key":"R7-14-20210309","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1001\/archinte.166.17.1842","article-title":"Impact of medication therapy discontinuation on mortality after myocardial infarction","volume":"166","author":"Ho","year":"2006","journal-title":"Arch Intern Med"},{"key":"R8-14-20210309","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1001\/archinte.166.17.1836","article-title":"Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus","volume":"166","author":"Ho","year":"2006","journal-title":"Arch Intern Med"},{"key":"R9-14-20210309","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1471-2261-6-48","article-title":"Adherence to cardioprotective medications and mortality among patients with diabetes and ischemic heart disease","volume":"6","author":"Ho","year":"2006","journal-title":"BMC Cardiovasc Disord"},{"key":"R10-14-20210309","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1093\/eurheartj\/ehs215","article-title":"ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force on the management of STsegment elevation acute myocardial infarction of the European Society of Cardiology (ESC)","volume":"33","author":"James","year":"2012","journal-title":"Eur Heart J"},{"key":"R11-14-20210309","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","article-title":"Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)","volume":"37","author":"Roffi","year":"2016","journal-title":"Eur Heart J"},{"key":"R12-14-20210309","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehw272","article-title":"2016\u200aESC\/EAS guidelines for the management of dyslipidemias","volume":"37","author":"Catapano","year":"2016","journal-title":"Eur Heart J"},{"key":"R13-14-20210309","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","article-title":"2013\u200aACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Stone","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R14-14-20210309","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"R15-14-20210309","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.phrs.2017.06.002","article-title":"Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group. The effect of statins on cardiovascular outcomes by smoking status: a systematic review and meta-analysis of randomized controlled trials","volume":"122","author":"Ursoniu","year":"2017","journal-title":"Pharmacol Res"},{"key":"R16-14-20210309","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.jacc.2017.07.752","article-title":"Optimizing cholesterol treatment in patients with muscle complaints","volume":"70","author":"Rosenson","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"R17-14-20210309","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12916-016-0550-5","article-title":"Is statin-modified reduction in lipids the most important preventive therapy for cardiovascular disease? A pro\/con debate","volume":"14","author":"Hobbs","year":"2016","journal-title":"BMC Med"},{"key":"R18-14-20210309","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s12916-015-0459-4","article-title":"Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group. Impact of statin therapy on coronary plaque composition: a systematic review and meta-analysis of virtual histology intravascular ultrasound studies","volume":"13","author":"Banach","year":"2015","journal-title":"BMC Med"},{"key":"R19-14-20210309","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/eurheartj\/ehs092","article-title":"European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts)","volume":"33","author":"Perk","year":"2012","journal-title":"Eur Heart J"},{"key":"R20-14-20210309","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ahj.2015.03.019","article-title":"Persistence with secondary prevention medications after acute myocardial infarction: insights from the TRANSLATE-ACS study","volume":"170","author":"Mathews","year":"2015","journal-title":"Am Heart J"},{"key":"R21-14-20210309","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejim.2014.12.014","article-title":"Reasons for discontinuation of recommended therapies according to the patients after acute coronary syndromes","volume":"26","author":"Gencer","year":"2015","journal-title":"Eur J Intern Med"},{"key":"R22-14-20210309","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1161\/CIRCULATIONAHA.108.768986","article-title":"Medication adherence: its importance in cardiovascular outcomes","volume":"119","author":"Ho","year":"2009","journal-title":"Circulation"},{"key":"R23-14-20210309","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0002-9343(02)01303-7","article-title":"Statins do not meet expectations for lowering low-density lipoprotein cholesterol levels when used in clinical practice","volume":"113","author":"Frolkis","year":"2002","journal-title":"Am J Med"},{"key":"R24-14-20210309","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1093\/eurheartj\/ehr132","article-title":"Fear of dying and inflammation following acute coronary syndrome","volume":"32","author":"Steptoe","year":"2011","journal-title":"Eur Heart J"},{"key":"R25-14-20210309","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1001\/jamainternmed.2013.2536","article-title":"The association of emergency department crowding during treatment for acute coronary syndrome with subsequent posttraumatic stress disorder symptoms","volume":"173","author":"Edmondson","year":"2013","journal-title":"JAMA intern Med"},{"key":"R26-14-20210309","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1001\/jama.1993.03510150053029","article-title":"Depression following myocardial infarction: impact on 6-month survival","volume":"270","author":"Frasure-Smith","year":"1993","journal-title":"JAMA"},{"key":"R27-14-20210309","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/j.amjcard.2005.07.070","article-title":"Frequency of distress and fear of dying during acute coronary syndromes and consequences for adaptation","volume":"96","author":"Whitehead","year":"2005","journal-title":"Am J Cardiol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000012225","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:26:20Z","timestamp":1620962780000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201809280-00014"}},"subtitle":["A retrospective analysis of patients presenting with first acute coronary syndromes"],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":27,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000012225","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]}}}